ONCS
Vanguard Group’s OncoSec Medical Incorporated ONCS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-57,488
| Closed | -$148K | – | 4645 |
|
|
2023
Q1 | $148K | Buy |
+57,488
| New | +$148K | ﹤0.01% | 4363 |
|
|
2022
Q4 | – | Sell |
-717,486
| Closed | -$350K | – | 4636 |
|
|
2022
Q3 | $350K | Sell |
717,486
-14,030
| -2% | -$6.84K | ﹤0.01% | 4307 |
|
|
2022
Q2 | $543K | Hold |
731,516
| – | – | ﹤0.01% | 4273 |
|
|
2022
Q1 | $842K | Hold |
731,516
| – | – | ﹤0.01% | 4264 |
|
|
2021
Q4 | $702K | Sell |
731,516
-35,015
| -5% | -$33.6K | ﹤0.01% | 4361 |
|
|
2021
Q3 | $1.63M | Buy |
766,531
+78,268
| +11% | +$167K | ﹤0.01% | 4122 |
|
|
2021
Q2 | $1.94M | Sell |
688,263
-181,319
| -21% | -$510K | ﹤0.01% | 3970 |
|
|
2021
Q1 | $4.15M | Buy |
869,582
+399,062
| +85% | +$1.9M | ﹤0.01% | 3625 |
|
|
2020
Q4 | $3.04M | Buy |
470,520
+277,696
| +144% | +$1.79M | ﹤0.01% | 3552 |
|
|
2020
Q3 | $652K | Buy |
192,824
+71,483
| +59% | +$242K | ﹤0.01% | 3759 |
|
|
2020
Q2 | $248K | Sell |
121,341
-5,120
| -4% | -$10.5K | ﹤0.01% | 3895 |
|
|
2020
Q1 | $160K | Sell |
126,461
-5,266
| -4% | -$6.66K | ﹤0.01% | 3891 |
|
|
2019
Q4 | $238K | Hold |
131,727
| – | – | ﹤0.01% | 3921 |
|
|
2019
Q3 | $259K | Sell |
131,727
-42,913
| -25% | -$84.4K | ﹤0.01% | 3920 |
|
|
2019
Q2 | $442K | Sell |
174,640
-757,283
| -81% | -$1.92M | ﹤0.01% | 3848 |
|
|
2019
Q1 | $519K | Sell |
931,923
-400
| -0% | -$223 | ﹤0.01% | 3758 |
|
|
2018
Q4 | $596K | Sell |
932,323
-1,025,904
| -52% | -$656K | ﹤0.01% | 3700 |
|
|
2018
Q3 | $2.74M | Buy |
1,958,227
+6,667
| +0.3% | +$9.33K | ﹤0.01% | 3428 |
|
|
2018
Q2 | $2.69M | Buy |
1,951,560
+33,916
| +2% | +$46.8K | ﹤0.01% | 3411 |
|
|
2018
Q1 | $3.61M | Buy |
1,917,644
+1,129,995
| +143% | +$2.12M | ﹤0.01% | 3271 |
|
|
2017
Q4 | $1.28M | Buy |
787,649
+329,138
| +72% | +$535K | ﹤0.01% | 3547 |
|
|
2017
Q3 | $439K | Buy |
458,511
+4,900
| +1% | +$4.69K | ﹤0.01% | 3780 |
|
|
2017
Q2 | $540K | Sell |
453,611
-110,495
| -20% | -$132K | ﹤0.01% | 3712 |
|
|
2017
Q1 | $722K | Buy |
564,106
+144,325
| +34% | +$185K | ﹤0.01% | 3668 |
|
|
2016
Q4 | $516K | Sell |
419,781
-22,623
| -5% | -$27.8K | ﹤0.01% | 3730 |
|
|
2016
Q3 | $757K | Buy |
442,404
+12,373
| +3% | +$21.2K | ﹤0.01% | 3647 |
|
|
2016
Q2 | $705K | Buy |
430,031
+13,025
| +3% | +$21.4K | ﹤0.01% | 3704 |
|
|
2016
Q1 | $1.06M | Buy |
417,006
+11,944
| +3% | +$30.4K | ﹤0.01% | 3580 |
|
|
2015
Q4 | $960K | Buy |
405,062
+28,262
| +8% | +$67K | ﹤0.01% | 3643 |
|
|
2015
Q3 | $1.94M | Buy |
+376,800
| New | +$1.94M | ﹤0.01% | 3390 |
|